Loading...
Market
How will Pfizer's stock price change within one week after Phase 3 results announcement for ponsegromab?
2
Resolution / Starting Odds
Increases by more than 10% • 25%
Decreases by more than 10% • 25%
Changes by less than 10% • 25%
No significant change • 25%
Stock market data from financial news websites or stock exchanges
Story
Pfizer's Ponsegromab Shows Promise in Phase 2 Study for Cancer Cachexia at ESMO24
Sep 14, 2024, 12:48 PM
Pfizer presented positive data from a Phase 2 study of its experimental drug, ponsegromab, at the ESMO24 conference. The drug showed promising results in treating cancer cachexia, a life-threatening condition characterized by severe weight loss and muscle wasting, which currently has no FDA-approved treatments. The study demonstrated that ponsegromab increased weight, improved appetite, and allowed patients to increase their physical activity. This development offers fresh hope for cancer patients suffering from this debilitating condition.
View original story
Similar markets
Increase by more than 10% • 25%
Increase by 0% to 10% • 25%
No significant change • 25%
Decrease • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Increases by more than 10% • 25%
Increases by 0-10% • 25%
Decreases by 0-10% • 25%
Decreases by more than 10% • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Increase > 20% • 25%
Increase 10-20% • 25%
Increase < 10% • 25%
Decrease • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Increase by more than 10% • 25%
Increase by 0-10% • 25%
Decrease by 0-10% • 25%
Decrease by more than 10% • 25%
Stock price increases by over 20% • 25%
Stock price increases by 10-20% • 25%
Stock price changes by less than 10% • 25%
Stock price decreases • 25%
Increase by more than 5% • 25%
Increase by 0% to 5% • 25%
Decrease by 0% to 5% • 25%
Decrease by more than 5% • 25%
Increase by more than 20% • 25%
Increase by 10% to 20% • 25%
Change less than 10% • 25%
Decrease • 25%